Motus Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $200M

Motus Therapeutics General Information

Description

Operator of a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases. The company's lead product candidate, relamorelin, is a ghrelin agonist for the treatment of diabetic gastroparesis, a GI complication of diabetes, and other GI functional disorders.

Contact Information

Website
www.motustx.com
Formerly Known As
Rhythm Metabolic, Rhythm Health
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 500 Boylston Street
  • 11th Floor
  • Boston, MA 02116
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Allergan
Corporate Office
  • 500 Boylston Street
  • 11th Floor
  • Boston, MA 02116
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Motus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 15-Dec-2016 $200M Completed Generating Revenue
1. Early Stage VC (Series A) 13-Aug-2015 Completed Generating Revenue
To view Motus Therapeutics’s complete valuation and funding history, request access »

Motus Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Motus Therapeutics’s complete cap table history, request access »

Motus Therapeutics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Deerfield Management Venture Capital Minority
Ipsen Corporation Minority
MPM BioImpact Venture Capital Minority
New Enterprise Associates Venture Capital Minority
OrbiMed Growth/Expansion Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Motus Therapeutics FAQs

  • When was Motus Therapeutics founded?

    Motus Therapeutics was founded in 2008.

  • Where is Motus Therapeutics headquartered?

    Motus Therapeutics is headquartered in Boston, MA.

  • What industry is Motus Therapeutics in?

    Motus Therapeutics’s primary industry is Drug Discovery.

  • Is Motus Therapeutics a private or public company?

    Motus Therapeutics is a Private company.

  • What is the current valuation of Motus Therapeutics?

    The current valuation of Motus Therapeutics is .

  • What is Motus Therapeutics’s current revenue?

    The current revenue for Motus Therapeutics is .

  • How much funding has Motus Therapeutics raised over time?

    Motus Therapeutics has raised $40M.

  • Who are Motus Therapeutics’s investors?

    Deerfield Management, Ipsen, MPM BioImpact, New Enterprise Associates, and OrbiMed are 5 of 9 investors who have invested in Motus Therapeutics.

  • When was Motus Therapeutics acquired?

    Motus Therapeutics was acquired on 15-Dec-2016.

  • Who acquired Motus Therapeutics?

    Motus Therapeutics was acquired by Allergan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process